Global capabilities
Delivering value beyond the test result
At Mayo Clinic Laboratories, laboratory medicine is about more than a test result — it’s about everything that contributes to providing answers for your patients. We develop individualized support solutions for each client that extend through all aspects of the relationship to ensure the delivery of answers, not just results.
Specialized testing areas include:
Global logistics and shipping
We develop unique relationships with each client to individualize logistics support, which is coordinated by a local team who ensures a seamless process before the first patient specimen is sent. Our specialists collaborate with packaging suppliers to create unique solutions that extend the stability of specimens traveling around the world.
These experts ensure specimens are handled carefully and efficiently through close connections to shipping carriers. The air carriers we work with are experienced with processing clinical specimens.
Optimized, expeditious processing
We recognize many medical conditions have a window of opportunity for the best possible outcomes. Our tests and processes are optimized to better serve patients and deliver results with outcomes in mind. We do not triage specimens across a network of labs or use a batch-testing business model. Result turnaround times are expedited by:
- Running tests continuously – your samples are processed alongside those from Mayo Clinic.
- A testing approach that incorporates comprehensive panels and algorithms when appropriate.
- Utilization of Lean and Six Sigma processes.
Reliable connectivity
We offer technology solutions to help our clients connect to us, including a secure online portal with interfacing capabilities that allows you to easily order tests and receive results. Our solutions include:
- Client-friendly test ordering through MayoLINK, which is available in eight languages.
- Expansive website with links to our open- access test catalog, which is updated daily and features comprehensive clinical information, including specimen requirements; clinical and interpretative information; performance; sample test reports; setup files; and pricing.
- 30 country-specific toll-free numbers.
News and updates
The latest
Dr. Bill Morice shares how clinical diagnostics are expanding to guide treatment and enable clinicians to target therapies more precisely.
John Mills, Ph.D., explains Mayo Clinic Laboratories' new neurofascin 155 (NF155) IgG4 antibody test, which is the first commercially available test in the U.S. to use flow cytometry to detect for NF155 antibodies and confirm diagnosis of CIDP.
This week's research roundup features: Therapeutic trials in adult FSGS: lessons learned and the road forward.
Dan O’Bryan didn’t think his dizziness and lightheadedness were anything to worry about. Nearly 100 miles away, the team at Mayo Clinic that was remotely monitoring Dan’s heart could see the truth.
Topic's Include: COVID-19 Queries: Can I develop a COVID infection from the vaccine? Mayo Clinic Q&A podcast: Breaking down COVID-19 vaccine booster approvals, and day of thanks for Mayo Clinic staff Nov. 26.
The following list includes updates posted to mayocliniclabs.com during the month of September.
Topic's Include: 3-D printed vaccine patch pioneered at UNC could revolutionize how we distribute vaccinations, Americans are getting Covid-19 Booster- no questions asked, and Tridemic? Minnesota doctors worry about flu season on top of pandemic.
This week on "Answers From the Lab,” William Morice II, M.D., Ph.D., chair of the Department of Laboratory Medicine and Pathology at Mayo Clinic and president of Mayo Clinic Laboratories, is joined for his weekly leadership update by Jason Hipp, M.D., Ph.D., chair of Mayo Clinic’s new Division of Computational Pathology and AI, to discuss how artificial intelligence and other forms of clinical informatics have the potential to transform laboratory medicine and pathology.
The NIH has awarded $40 million to Mayo Clinic to develop a comprehensive biorepository as the source of clinical samples for long COVID research studies.
Linda Hasadsri, M.D., Ph.D., explains how Mayo Clinic Laboratories’ inclusive approach to mitochondrial disease testing expedites diagnosis. Using innovative methodologies like custom reagents and droplet digital PCR enables precision insights on prognosis and treatment options.
This week's research roundup features: Effect of probiotics on incident ventilator-associated pneumonia in critically Ill patients: A randomized clinical trial.
Topic's Include: COVID-19 Media Only News Briefing: Pfizer low-dose vaccine for kids, Mayo Clinic leads biorepository core for new nationwide research on long-term symptoms of COVID-19, and Mayo Clinic will begin offering booster vaccines.
Representing Mayo Clinic at the event, Dr. William Morice contributed his expertise and experience as leaders from around the world redoubled their commitment to end the COVID-19 pandemic.